Code of Federal Regulations > Title 21 > Chapter I > Part 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

U.S. Code of Federal Regulations

Regulations most recently checked for updates: Mar 31, 2023

Subpart A [§ 212.1 - § 212.5] - General Provisions

Subpart B [§ 212.10 - § 212.10] - Personnel and Resources

Subpart C [§ 212.20 - § 212.20] - Quality Assurance

Subpart D [§ 212.30 - § 212.30] - Facilities and Equipment

Subpart E [§ 212.40 - § 212.40] - Control of Components, Containers, and Closures

Subpart F [§ 212.50 - § 212.50] - Production and Process Controls

Subpart G [§ 212.60 - § 212.61] - Laboratory Controls

Subpart H [§ 212.70 - § 212.71] - Finished Drug Product Controls and Acceptance

Subpart I [§ 212.80 - § 212.80] - Packaging and Labeling

Subpart J [§ 212.90 - § 212.90] - Distribution

Subpart K [§ 212.100 - § 212.100] - Complaint Handling

Subpart L [§ 212.110 - § 212.110] - Records